Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers

• Published in: American journal of respiratory cell and molecular biology Vol. 15; no. 1; p. 45
• Main Authors: Kitagawa, Y, Wong, F, Lo, P, Elliott, M, Verburgt, L M, Hogg, J C, Daya, M
• Format: Journal Article
• Language: English
• Published: United States 01-07-1996
• Subjects: Adenocarcinoma - genetics; Aged; Base Sequence; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Squamous Cell - genetics; Codon - genetics; Female; Gene Expression Regulation, Neoplastic - genetics; Genes, ras - genetics; Humans; Immunohistochemistry; Lung Neoplasms - genetics; Male; Middle Aged; Molecular Sequence Data; Mutation - physiology; Protein-Tyrosine Kinases - genetics; Proto-Oncogene Proteins - genetics; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 - genetics
• ISSN: 1044-1549
• DOI: 10.1165/ajrcmb.15.1.8679221

We investigated expression of Bcl-2, mutations in p53, and K-ras oncogene in 51 resected human non-small cell lung cancers. The studies were designed to test for the possibility of cooperativity between these oncogenes and p53 in the pathogenesis of lung cancer. An inverse relationship was found between expression of Bcl-2 and mutant p53 by immunohistochemistry (P < 0.01; Fisher exact test), suggesting that either Bcl-2 overexpression or mutations in p53 may fulfill a critical function in the pathogenesis of human non-small cell lung cancers. Tumors that harbored K-ras codon 12 mutations seldom had p53 mutations or overexpressed Bcl-2. Statistical analysis of these data showed that mutations in p53 and K-ras or overexpression of Bcl-2 and mutations in K-ras occurred at a frequency that could be explained only by chance [P > 0.1 in each case (Fisher exact tests)]. This suggests that cooperativity between mutant K-ras and mutant p53 or mutant K-ras and overexpressed Bcl-2 is not a common mechanism in the pathogenesis of human non-small cell lung cancers.